Valeant Again Boosts Allergan Bid, This Time To $53B
Valeant Pharmaceuticals International Inc. said Friday it would substantially increase its bid for Botox maker Allergan Inc. to roughly $53.3 billion if the California-based target opens itself to good faith negotiations...To view the full article, register now.
Already a subscriber? Click here to view full article